Showing results (1-10 of 268) with videos related to
Sort By:
Pageof 27
International Journal of Clinical Practice. Supplement|January 6, 2000
Efavirenz: resistance and cross-resistanceB ClotetThe Journal of General Virology|January 21, 2000
Human immunodeficiency virus type 1 population bottleneck during indinavir therapy causes a genetic drift in the env quasispeciesA Ibáñez, B Clotet, M A MartínezJournal of Medical Virology|October 27, 1999
Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitorsM Cabana, B Clotet, M A MartínezVirology|March 22, 2001
Absence of genetic diversity reduction in the HIV-1 integrated proviral LTR sequence population during successful combination therapyA Ibáñez, B Clotet, M A MartínezHIV Medicine|January 20, 2006
Analysis of genotypic and phenotypic clinical cut-off levels for ritonavir-boosted saquinavirA Hill, S Walmsley, B Clotet, et al.Journal of Viral Hepatitis|May 16, 2007
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patientsB Ramos, M Núñez, A Rendón, et al.Actas Dermo-Sifiliograficas|May 26, 2009
[Cutaneous drug reactions in HIV-infected patients in the HAART era]M Blanes, I Belinchón, J PortillaBoletin Medico Del Hospital Infantil De Mexico|May 1, 1978
[Reye's syndrome: pathological aspects]M Reynoso García, J Portilla AguilarAIDS and Behavior|May 14, 2024
Health-Related Quality of Life in People with Advanced HIV Disease, from 1996 to 2021: Systematic Review and Meta-analysisI Portilla-Tamarit, M Rubio-Aparicio, M J Fuster-RuizdeApodaca, et al.Enfermedades Infecciosas Y Microbiologia Clinica|December 22, 1998
[Intestinal parasitic infections and leishmaniasis in patients with HIV infection]A Moreno-Camacho, R López-Vélez, A Muñoz Sanz, et al.Pageof 27